# US 2016/0257986 A1 · Bacterial Diagnosis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0257986 A1
- Document ID: US20160257986A1
- Status: Published application
- Kind: A1
- Application number: 15/153,718
- Filed: 2016-05-12
- Published: 2016-09-08
- Earliest claimed: 2013-11-12
- Assignees: SRI International
- Applicants: Sri International
- Inventors: Peter B. Madrid; Xiaohe Liu
- Web page: https://patentgrep.com/patent/US20160257986A1

## CPC

- C12Q 1/04: Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)}
- G01N 33/56911: {Bacteria}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Antibiotic susceptibility profile and the bacterial species identification are reported and determined in a single diagnostic test. The method simultaneously reports for a sample of bacteria the identities of the bacteria and their respective antibiotic susceptibilities, the method comprising step(s): contacting the bacteria with antibiotics, a phenotypic fluorescent sensor of antibiotic susceptibility and species- or strain-specific affinity probes, wherein the probes and sensor simultaneously report, respectively, the identities of the bacteria and their respective antibiotic susceptibilities.

## Claims

### Claim 1

A method of simultaneously reporting for a sample of bacteria the identities of the bacteria and their respective antibiotic susceptibilities, the method comprising step(s):
contacting the bacteria with antibiotics, a phenotypic fluorescent sensor of antibiotic susceptibility and species- or strain-specific affinity probes, wherein the probes and sensor simultaneously report, respectively, the identities of the bacteria and their respective antibiotic susceptibilities.

### Claim 2 (depends on 1)

The method of claim 1 wherein the probes are immobilized at discrete loci, with a panel of the loci for each specificity, and the contacting step comprises contacting the bacteria with the probes, and then contacting the probe-bound bacteria of each panel with a corresponding antibiotic and the sensor.

### Claim 3 (depends on 1)

The method of claim 1 wherein the contacting step comprises contacting the bacteria with the sensor, then dividing bacteria into subsets, then contacting each of the subsets with a corresponding antibiotic and the probes, wherein the probes of each specificity are uniquely labeled.

### Claim 4 (depends on 1)

The method of claim 1 wherein the sensor reports reactive oxygen species as an indication of antibiotic susceptibility.

### Claim 5 (depends on 2)

The method of claim 2 wherein the sensor reports reactive oxygen species as an indication of antibiotic susceptibility.

### Claim 6 (depends on 3)

The method of claim 3 wherein the sensor reports reactive oxygen species as an indication of antibiotic susceptibility.

### Claim 7 (depends on 1)

The method of claim 1 wherein the probes are antibodies.

### Claim 8 (depends on 2)

The method of claim 2 wherein the probes are antibodies.

### Claim 9 (depends on 3)

The method of claim 3 wherein the probes are antibodies.

### Claim 10 (depends on 1)

The method of claim 1 wherein the sensor is dihydrorhodamine 123.

### Claim 11 (depends on 1)

The method of claim 1 effected in less than 3 hours.

### Claim 12 (depends on 1)

The method of claim 1 which determines the antibiotic susceptibility profile and identify of ten pathogenically relevant bacterial species in a single diagnostic test.

### Claim 13 (depends on 1)

The method of claim 1 wherein the sample is a physiological specimen that is sputum, blood, urine or fecal.

### Claim 14 (depends on 1)

The method of claim 1 further comprising the step of simultaneously detecting probe-bacteria binding and sensor signaling as indicators of the identities of the bacteria and their respective antibiotic susceptibilities, respectively.

### Claim 15 (depends on 2)

The method of claim 2 further comprising the step of simultaneously detecting probe-bacteria binding and sensor signaling as indicators of the identities of the bacteria and their respective antibiotic susceptibilities, respectively.

### Claim 16 (depends on 3)

The method of claim 3 further comprising the step of simultaneously detecting probe-bacteria binding and sensor signaling as indicators of the identities of the bacteria and their respective antibiotic susceptibilities, respectively.

### Claim 17 (depends on 1)

The method of claim 1 wherein the sensor reports reactive oxygen species as an indication of antibiotic susceptibility, the probes are antibodies, the sensor is dihydrorhodamine 123, the method is effected in less than 3 hours and determines the antibiotic susceptibility profile and identify of ten pathogenically relevant bacterial species in a single diagnostic test.

### Claim 18 (depends on 2)

The method of claim 2 wherein the sensor reports reactive oxygen species as an indication of antibiotic susceptibility, the probes are antibodies, the sensor is dihydrorhodamine 123, the method is effected in less than 3 hours and determines the antibiotic susceptibility profile and identify of ten pathogenically relevant bacterial species in a single diagnostic test.

### Claim 19 (depends on 3)

The method of claim 3 wherein the sensor reports reactive oxygen species as an indication of antibiotic susceptibility, the probes are antibodies, the sensor is dihydrorhodamine 123, the method is effected in less than 3 hours and determines the antibiotic susceptibility profile and identify of ten pathogenically relevant bacterial species in a single diagnostic test.

### Claim 20 (depends on 1)

The method of claim 1 wherein the sensor reports reactive oxygen species as an indication of antibiotic susceptibility, the probes are antibodies, the sensor is dihydrorhodamine 123, the method is effected in less than 3 hours and determines the antibiotic susceptibility profile and identify of ten pathogenically relevant bacterial species in a single diagnostic test, and further comprising the step of simultaneously detecting probe-bacteria binding and sensor signaling as indicators of the identities of the bacteria and their respective antibiotic susceptibilities, respectively.
